The share price recently dropped by too much. It's just making it's way back up to where it should be at, that's my opinion.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025